Late infections following allogeneic bone marrow transplantation: Suggested strategies for prophylaxis

Leukemia and Lymphoma

Volumn 26, Issue 1-2, 1997, Pages 1-15

  Roy, Vivek ^a   Ochs, Lorre ^a   Weisdorf, Daniel ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Bone marrow transplant; Immune defects; Immunization; Immunoglobulin therapy; Infections; Prophylaxis

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; COTRIMOXAZOLE; CYCLOSPORIN A; DIPHTHERIA TETANUS TOXOID; ERYTHROMYCIN; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN; INFLUENZA VACCINE; ITRACONAZOLE; MEASLES MUMPS RUBELLA VACCINE; PENICILLIN G; PENICILLIN V POTASSIUM; PENTAMIDINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; SULFANILAMIDE DERIVATIVE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANAPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CHEMOPROPHYLAXIS; CYTOMEGALIC INCLUSION BODY DISEASE; DRUG COST; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; GRAFT INFECTION; GRAFT VERSUS HOST REACTION; HERPES; HERPES ZOSTER; HIGH RISK PATIENT; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MYCOSIS; NEPHROTOXICITY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PNEUMOCYSTOSIS; PRIORITY JOURNAL; PROTOZOAL INFECTION; REVIEW;

EID: 0030811475     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709109152     Document Type: Review

References (77)

1. Ochs, L., Shu, X. O., Miller, J., Enright, H., Wagner, J., Filipovich, A., Miller, W. and Weisdorf, D. (1995). Late infections after allogeneic bone marrow transplantation: comparison of incidence in related and unrelated donor transplant recipients, Blood, 86, 3979-3986.
2. Hoyle, C. and Goldman, J. M. (1994). Life-threatening infections occurring more than 3 months after BMT, Bone Marrow Transplantation, 14, 247-252.
3. Atkinson, K., Storb, R., Prentice, R. L., Weiden, P. L., Sullivan, K. M., Witherspoon, R. P., Noel, D. and Thomas, E. D. (1979). Analysis of late infections in 89 long-term survivors of bone marrow transplantation, Blood, 53, 720-731.
4. Atkinson, K., Farewell, V., Storb, R., Tsoi, M., Sullivan, K. M., Witherspoon, R. P., Fefer, A., Clift, R., Goodell, B. and Thomas, E. D. (1982). Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease, Blood, 60, 714-720.
5. Paulin, T., Ringden, O., Nilsson, B., Lonnqvist, B. and Gohrton, G. (1987). Variables predicting bacterial and fungal infections after allogeneic marrow engraftment, Transplantation, 43, 393-398.
6. Sullivan, K. M., Mori, M., Sanders, J., Siadak, M., Witherspoon, R. P., Anasetti, C., Applebaum, F. R., Bensinger, W., Bowden, R., Buckner, C. D., Clark, J., Crawford, S., Deeg, H. J., Doney, K., Flowers, M., Hansen, J., Loughran, T., Martin, P., McDonald, G., Pepe, M., Petersen, F. B., Scheuning, F., Stewart, P. and Storb, R. (1992). Late complications of allogeneic and autologous marrow transplantation, Bone Marrow Transplantation, 10 suppl 1, 127-134.
7. Zimmerli, W., Zarth, A., Gratwohl, A. and Speck, B. (1991). Neutrophil function and pyogenic infections in bone marrow transplant recipients, Blood, 77, 393-399
8. Al-Eid, M. A., Tutschka, P. J., Wagner, H. N. J., Santos, G. W and Tsan, M. F. (1983). Functional asplenia in patients with chronic graft-versus-host disease: Concise communication, Journal of Nuclear Medicine, 24, 1123.
9. Kahls, P., Panzer, S., Kletter, K., Minar, E., Stain-Kos, M., Walter, R., Lechner, K. and Hinterberger, W. (1988). Functional asplenia after bone marrow transplantation: a late complication related to extensive chronic graft-versus-host disease, Annals of Internal Medicine, 109, 461-464.
10. Sable, C. A. and Donowitz, G. R. (1994) Infections in bone marrow transplant recipients, Clinical Infectious Diseases, 18, 273-284.
11. Marks, D. I., Cullis, J. O., Ward, K. M., Lacey, S., Szydlo, R., Hughes, T. P., Schwarer, A. P., Lutz, E., Barret, A. J., Hows, J. M., Batchelor, R. and Goldman, J. M. (1993). Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors, Annals of Internal Medicine, 119, 207-214.
12. Sullivan, K. M., Agura, E., Anasetti, C., Bearman, B. S., Erickson, K., Flowers, M., Hansen, J., Loughran, T., Martin, P., Matthews, D., Petersdorf, E., Radich, J., Riddell, S., Rovira, D., Sanders, J., Scheuning, F., Siadak, M., Storb, R. and Witherspoon, R. P. (1991). Chronic graft-versus-host disease and other late complications of bone marrow transplantation, Seminars in Hematology, 28, 250-259.
13. Gale, R., Opelz, G., Mickey, M. R., Graze, P. R. and Saxon, A. (1978). Immunodeficiency following allogeneic bone marrow transplantation. Transplantation Proceedings, 10, 223-235.
14. Elfenbein, G. J., Anderson, P. N., Humphrey, R. L., Mullins, G. M., Sensenbrenner, L., Wands, J. R. and Santos, G. W. (1976). Immune system reconstitution following allogeneic bone marrow transplantation in man A multiparameter analysis, Transplantation Proceedings, 8, 641-646.
15. Atkinson, K. (1990). Reconstitution of the haemopoietic and immune systems after marrow transplantation, Bone Marrow Transplantation, 5, 209-226.
16. Atkinson, K., Luckhurst, E., Penny, R., Warren, H and Biggs, J. (1983). Immunologic reconstitution after allogeneic marrow transplantation in man, Transplantation Proceedings, 15, 474-479.
17. Witherspoon, R. P., Lum, L. G. and Storb, R. (1984). Immunological reconstitution after human marrow grafting, Seminars in Hematology, 21, 2-10
18. Paulin, T., Ringden, O. and Nikson, B. (1987). Immunological recovery after bone marrow transplantation: Role of age, graft-versus-host disease, prednisolone treatment and infections, Bone Marrow Transplantation, 1, 317-328.
19. Lum, L. G., Orcutt-Thordarson, N., Seigneuret, M. C. and Storb, R. (1982). The regulation of Ig synthesis after marrow transplantation IV. T4 and T8 subset function in patients with chronic graft-versus-host disease, Journal of Immunology, 129, 113-119.
20. Witherspoon, R. P., Storb, R., Oachs, H. D., Flournoy, N., Kopecky, K. J., Sullivan, K. M., Deeg, J. H., Sosa, R., Noel, D. R., Atkinson, K. and Thomas, E. D. (1981). Recovery of antibody production in human allogeneic marrow graft recipients: Influence of time post transplantation, the presence or absence of graft versus host disease, and anti-thymocyte globulin treatment, Blood, 58, 360-368.
21. Territo, M. C., Gale, R. P. and Cline, M. J. (1977). Neutrophil function in bone marrow transplant recipients, British Journal of Haematology, 35, 245-250.
22. Sosa, R., Weiden, P. L., Storb, R., Syrotuck, J. and Thomas, E. D. (1980). Granulocyte function in human allogeneic marrow graft recipients. Experimental Hematology, 8, 1183-1189.
23. Friedrich, W., O'Reilly, R. J., Koziner, B., Gebhard, D. F., Good, R. A. and Evans, R. L. (1982). T-lymphocyte reconstitution in recipients of bone marrow transplants with and without GVHD: Imbalances of T-cell subpopulations having unique regulatory and cognitive functions, Blood, 59, 696-701.
24. Witherspoon, R. P., Matthews, D., Storb, R., Atkinson, K., Cheever, M., Deeg, H. J., Doney, K., Kalbfleisch, J., Noel, D., Prentice, R., Sullivan, K. M. and Thomas, E. D. (1984). Recovery of in vivo cellular immunity after human marrow grafting. Influence of time post-grafting and acute graft-versus-host disease, Transplantation, 37, 145-150.
25. Tsoi, M. S., Storb, R., Dobbs, S., Kopecky, K. J., Santos, E., Weiden, P. L. and Thomas, E. D. (1979). Nonspecific suppressor cells in patients with chronic graft-versus-host disease after marrow grafting. Journal of Immunology, 123, 1970-1976.
26. Witherspoon, R. P., Lum, L. G., Storb, R. and Thomas, E. D. (1982). In vitro regulation of immunoglobulin synthesis after human transplantation. II. Deficient T and non-T lymphocyte function within 3-4 months of allogeneic, syngeneic, or autologous marrow grafting for hematologic malignancy, Blood, 59, 844-850.
27. Aucouturier, P., Barra, A., Intrator, L., Cordonnier, C., Schulz, D., Durate, F., Vernant, J. P. and Pred'homme, J. L. (1987). Long lasting IgG subclass, and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation, Blood, 70, 779-785.
28. Abedi, M. R., Hammarstrom, L., Ringden, O. and Edvard-Smith, C. I. (1990). Development of IgA deficiency after bone marrow transplantation, Transplantation, 50, 415-421.
29. Lum, L. G. (1987). The kinetics of immune reconstitution after human marrow transplant, Blood, 69, 369-380.
30. Lum, L. G., Noges, J. E., Beatty, P., Martin, P. J., Deeg, J., Dooney, K. C., Loughram, T., Sullivan, K. M., Witherspoon, R. P., Thomas, E. D. and Storb, R. (1988) Transfer of specific immunity in marrow recipients given HLA mismatched, T cell depleted or HLA identical marrow grafts. Bone Marrow Transplantation, 3, 339-406.
31. Clark, J. G., Crawford, S., Madtes, D. K. and Sullivan, K. M. (1989). Obstructive lung disease after allogeneic marrow transplantation, Annals of Internal Medicine, 111, 368-376.
32. Han, C. S., Miller, W., Haake, R. and Weisdorf, D. (1994). Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications, Bone Marrow Transplantation, 13, 277-283.
33. Locksley, R. M., Flournoy, N., Sullivan, K. M. and Meyers, J. D. (1985). Infection with varicella-zoster virus after marrow transplantation. Journal of Infectious Diseases, 152, 1172-1181.
34. Hertz, M. I., Englund, J. A., Snover, D , Bitterman, P. B. and McGlave, P. (1989). Respiratory syncitial virus-induced acute lung injury in adult patients with bone marrow transplantation: a clinical approach and review of literature, Medicine, 68, 269-281.
35. Wendt, C. H., Weisdorf, D. J., Jordan, M. C., Balfour, H. H. and Hertz, M. I. (1992). Parainfluenza virus respiratory infection after bone marrow transplantation, New England Journal of Medicine. 326, 921-926.
36. Apperley, J. F., Rice, S. J., Bishop, J. A., Chia, Y. C., Krausz, T., Gardner, S. D. and Goldman, J. M. (1987). Late-onset hemorrhagic cystitis associated with urinary excretion of polyomavirus after bone marrow transplantation, Transplantation, 43, 108-112.
37. Shields, A. F., Hackman, R. F., Fife, K. H., Corey, K. and Meyers, J. D. (1985). Adenovirus in patients undergoing bone marrow transplantation, New England Journal of Medicine, 312, 529-533.
38. Verfaillie, C., Weisdorf, D., Haake, R., Hostetter, M., Ramsay, N. K. C. and McGlave, P. (1991). Candida infections in bone marrow transplant recipients, Bone Marrow Transplantation, 8, 177-184.
39. Wingard, J. R., Mellits, E. D., Sostrin, M. B., Chen, D. Y., Burns, W. H., Santos, G. W., Vriesendorp, H. M., Beschorner, W. E. and Saral, R. (1988). Interstitial pneumonitis after allogeneic bone marrow transplantation, Medicine, 67, 175-186
40. Krowka, M. J., Rosenow, E. C. and Hoagland, H. (1985). Pulmonary complications of bone marrow transplantation, Chest, 87, 237-246.
41. Tuan, I. Z., Dennison, D. and Weisdorf, D. J. (1992). Pneomocystis carinii pneumonitis following bone marrow transplant, Bone Marrow Transplantation, 10, 267-272.
42. Sullivan, K. M., Dahlberg, S., Storb, R. et al. (1983). Infection prophylaxis with chronic graft-versus-host disease, Experimental Hematology, 11, 193.
43. Bowden, R. A., Slichter, S. J., Sayers, M., Weisdorf, D., Cays, M., Schoch, G., Banaji, M., Haake, R., Welk, K., Fisher, L., McCullough, J. and Miller, W. (1995). A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant, Blood, 86, 3598-3603.
44. Meyers, J. D., Reed, E. C., Shepp, D. H., Thornquist, M., Dandiker, P. S., Vicary, C. A., Flournoy, N., Kirk, L. E., Kersey, J. H., Thomas, E. D. and Balfour, H. H. (1988). Acyclovir for the prevention of cytomegalovirus infection and disease after bone marrow transplantation, New England Journal of Medicine, 318, 70-75.
45. Prentice, H. G., Gluckman, E., Powles, R. L., Ljungman, P., Milpied, N., Fernandez Ranada, J. M., Mandelli, F., Kennedy, L. and Bell, A. R. (1994). Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. (European Acyclovir for CMV Prophylaxis Study Group), Lancet, 343, 749-753.
46. Winston, D. J., Ho, W. G., Bartoni, K., Du Mond, C., Ebeling, D. F., Buhles, W. C. and Champlin, R. E. (1993). Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial. Annals of Internal Medicine. 118, 179-184.
47. Goodrich, J. M., Bowden, R. A., Fisher, L., Keller, C., Schoch, G. and Meyers, J. D. (1993). Ganciclovir prophylaxis to prevent cytomegalovirus disease after bone marrow transplant, Annals of Internal Medicine, 118, 173-178.
48. Atkinson, K., Downs, K., Golenia, M., Biggs, J., Marshall, G., Dodds, A. and Concannon, A. (1991). Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: Absence of clinical cytomegalovirus infection, British Journal of Haematology, 79, 57-62.
49. Reusser, P., Gambertoglio, J. G., Lilleby, K. and Meyers, J. D. (1992). Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients, Journal of Infectious Diseases, 163, 473-479.
50. Shepp, D. H., Dandliker, P. S. and Meyers, J. (1986). Treatment of Vericalla-zoster infection in severely immunocompromized patients A randomized comparison of acyclovir and vidarabine, New England Journal of Medicine, 314, 208-212.
51. Hughes, W. T., Rivera, G. K., Schnell, M. J., Thornton, D. and Lott, D. (1987). Successful intermittent chemoprophylaxis for pneumocystis carinii pneumonitis, New England Journal of Medicine, 316, 1627-1632.
52. Olsen, S., Renlund, D. G., O'Connell, J. B., Taylor, D. O., Lasseter, J. E., Eastburn, T. E., Hammond, E. H. and Bristow, M. R. (1993). Prevention of pneumocystis pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole, Transplantation, 56, 359-362.
53. Leoung, G. S., Feigal, D. W. J., Montgomery, A. B., Corkery, K., Wardlaw, L., Adams, M., Busch, D., Dordon, D., Jacobson, M. A., Volberding, P. A. and Abrams, D. (1990). Aerosolized pentamidine for prophylaxis against pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial, New England Journal of Medicine, 323, 769-775.
54. Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., Powderly, W. G., Silber, J. L., Horowitz, H., Lichtin, A., Wolff, S. N., Mangan, K. F., Silver, S. M., Weisdorf, D., Ho, W. G., Gilbert, G. and Buell, D. (1992). A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation, New England Journal of Medicine, 326, 835-851
55. Alangaden, G., Chandrashekar, P. H., Bailey, E., Khaliq, Y. and Bone Marrow Transplantation Team. (1994) Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation, Bone Marrow Transplantation, 14, 919-924.
56. Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E. and Saral, R. (1991). Increase in Candida krusei infections among patients with bone marrow transplantation and neutropenia treated with fluconazole, New England Journal of Medicine, 325, 1274-1277.
57. Wingard, J. R., Merz, W. G., Rinaldi, M. G., Miller, C. B., Karp, J. E. and Saral, R. (1993). Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients, Antimicrobial Agents & Chemotherapy, 37, 1847-1849.
58. Peterson, F. B., Bowden, R. A., Thornquist, M. et al. (1987). The effect of prophylactic immunoglobulin on the incidence of septicemia in marrow transplant recipients, Bone Marrow Transplantation, 2, 141-148.
59. Sullivan, K. M., Kopecky, K. J., Jacom, J., Fisher, L., Buckner, C. D., Meyers, J. D., Counts, G. W., Bowden, R. A., Petersen, F. B., Witherspoon, R. P., Budinger, M. D., Schwartz, R. S., Applebaum, F. R., Clift, R. A., Hansen, J. A., Sanders, J. E., Thomas, D. E. and Storb, R. (1990). Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation, New England Journal of Medicine, 323, 705-712.
60. Graham-Pole, J., Casper, C. J., Elfenbein, G., Gross, S., Herzig, R., Koch. P., Mahoney, D., Marcus, R., Munoz, L., Pick, T., Spruce W., Steuber, P. and Weiner, R. (1988). Intravenous immunoglobulin may lesson all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukemia: a pediatric oncology group study, Bone Marrow Transplantation, 3, 559-566.
61. Sullivan, K. M., Kopecky, K., Witherspoon, R. P. et al. (1990). Intravenous immunoglobulin (IVIg) for prevention of late infections after bone marrow transplantation (BMT) (abstract). Experimental Hematology, 18, 689.
62. Sullivan, K. M., Storek, J., Kopecky, K. J., Jacom, J., Longston, G., Flowers, M., Siadak, M., Nims, J., Witherspoon, R. P., Anasetti, C., Applebaum, F. R., Bowden, R. A., Buckner, C. D., Crawford, S. W., Deeg, H. J., Hansen, J. A., McDonald, G. B., Sanders, J. E. and Storb, R. (1996). A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infections and chronic graft-versus-host disease after bone marrow transplantation: Clinical outcome and effect on subsequent immune recovery, Biology of blood and Marrow Transplantation, 2, 44-53.
63. Copelan, E. A., Betchel, T. P., Klein, J. P., Klein, J. L., Tutschka, P., Kapoor, N., Featheringham, N. C. and Avalos, B. R. (1994). Controlled trial of orally administered immunoglobulin following bone marrow transplantation, Bone Marrow Transplantation, 13, 87-91.
64. Giebink, G. S., Warkentoin, P. I., Ramsay, N. K. C. and Kersey, J. H. (1986). Titer of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine, Journal of Infectious Diseases, 154, 590-596.
65. Winston, D. J., Winston, G. H., Schiffman, G., Champlin, R. E., Feig, S. A. and Gale, R. P. (1983). Pneumococcal vaccination of recipients of bone marrow transplantation, Archives of Internal Medicine, 143, 1735-1737.
66. Barra, A., Cordonnier, C., Preziosi, M. P., Intrator, L., Hessel, L., Fritzell, B. and Preud'homme, J. L. (1992). Immunogenecity of Haemophilus influenzae type b conjugate vaccine an allogeneic bone marrow recipients. Journal of Infectious Diseases, 166, 1201-1208.
67. Robbins, J. B. and Schneerson, R. (1990). Polysaccharide-protein conjugates: A new generation of vaccines, Journal of Infectious Diseases, 161, 821-832.
68. Gardener, P. and Schaffner, W. (1993). Immunization of adults, New England Journal of Medicine, 328, 1252-1258.
69. Engelhard, D., Nagler, A., Hardan, I., Morag, A., Aker, M., Baciu, H., Strauss, N., Parag, G., Naparstek, E., Ravid, Z., Or, R., Slavin, S. and Zakay-Rones, Z. (1993). Antibody response to a two-dose regimen of influenza vaccine in allogeneic T-cell depleted and autologous BMT recipients. Bone Marrow Transplantation, 11, 1-5.
70. Yeung, C. Y. and Liang, D. C. (1992). Varicella vaccine in children with acute lymphoblastic leukemia and non-hodgkin lymphoma. Pediatric Hematology and Oncology, 9, 29-34.
71. Diaz, P. S., Au, D., Smith, S., Amylon, M., Link, M., Smith, S. and Arvin, A. M. (1991). Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their sibling, Pediatrics, 87, 166-170.
72. Ljungman, P., Wicklund-Hammarsten, M., Duraj, V., Hammarstrom, L., Lonnqvist, B., Paulin, T., Ringden, O., Pepe, M. S. and Gahrton, G. (1990). Response to tetanus toxoid immunization after allogeneic bone marrow transplant, Journal of Infectious Diseases, 162, 496-500.
73. Ljungman, P., Duraj, V. and Magnius, L. (1991). Response to immunization against polio after allogeneic bone marrow transplantation, Bone Marrow Transplantation, 7, 89-93.
74. Ljungman, P., Fridell, E., Lonnqvist, B., Bolme, P., Bottiger, M., Gahrton, G., Linde, A., Ringden, O. and Wahren, B. (1989) Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine, Journal of Infectious Diseases, 159, 610-615.
75. Somani, J. and Larson, R. A. (1995). Reimmunization after allogeneic bone marrow transplantation, American Journal of Medicine, 98, 389-398.
76. Molrine, D. C., Guinan, E. C., Antin, J. H., Parsons, S. K., Weinstein, H. J., Wheeler, C., McGangle, C., Blanding, P., Phillips, N. R., Kinsella, K., Deans, K., Ciamarra, A., Goorin, A., George, S. and Ambrosino, M. (1996). Donor immunization with Haemophilus influence type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation, Blood, 87, 3012-3018
77. Gottlieb, D. J., Cryz, S. J., Furer, E., Que, J. U., Prentice, H. G., Duncombe, A. S. and Brenner, M. K. (1990). Immunity against Pseudomonas aerogenosa adoptively transferred to bone marrow transplant recipients, Blood, 76, 2470-2475.